SynthesisAnnals of medicine2025

Efficacy and safety of IL-23p19 and IL-12/23p40 inhibitors in moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.

Motoki Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.